ライシンメチルトランスフェラーゼ2C欠乏症を標的とする:乳がん治療と予後における新たな境界線
Shuangmei Tong1, Qiu Wang1,2, Yun Chen1
1Department of Clinical Pharmacy, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Clinical and translational medicine
|February 12, 2026
まとめ
リシンメチルトランスフェラーゼ2 (KMT2C) の機能喪失変異は,乳がんの転移と治療抵抗を促進する. KMT2Cを理解する
科学分野:
- 腫瘍学 腫瘍学
- 分子生物学は分子生物学である.
- エピジェネティクス エピジェネティクス
背景:
- リジンメチルトランスフェラーゼ2 (KMT2C) の機能喪失変異は,乳がんにおいて一般的です.
- KMT2C変異は,腫瘍の異質性の増加,攻撃的行動,および不良の予後と相関しています.
- KMT2C欠乏が転移と治療抵抗を引き起こす正確なメカニズムは,完全に理解されていません.
研究 の 目的:
- 乳がんの病原性におけるKMT2Cの複雑な役割を見直す.
- KMT2Cが主要な腫瘍性シグナル伝達経路と相互作用することを強調する.
- KMT2C欠乏性乳がんに対する潜在的な治療戦略について議論する.
主な方法:
- 乳がんにおけるKMT2Cの機能に関する包括的な文献レビュー.
- KMT2CがIFNγ-EMT/MET,MAPK/ERK,PI3K/AKT/mTORなどの信号ネットワークと相互作用する分析.
- KMT2CとKDM6A-MMP3の制御回路の相互作用を検証する.
主要な成果:
- KMT2C欠乏症は,重要な腫瘍性シグナリングネットワークに影響を与えます.
- KMT2CはIFNγ-EMT/MET,MAPK/ERK,PI3K/AKT/mTOR,およびKDM6A-MMP3.3を含む経路と相互作用する.
- これらの相互作用は,腫瘍の進行と治療上の課題に寄与する.
結論:
- KMT2Cは,乳がんにおける腫瘍抑制剤として重要な役割を果たしています.
- KMT2Cの分子メカニズムを理解することは,標的型療法のための論理的根拠を提供します.
- KMT2C変異性腫瘍を標的とした精密療法が有望な道である.
関連する概念動画
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
Cancer Therapies
10.2K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
Gene Therapy
27.7K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.7K
Group Therapy
460
Group therapy is a sociocultural approach to psychological treatment, where individuals with shared psychological challenges come together under the guidance of a mental health professional. This therapeutic modality offers unique opportunities for individuals to connect, share, and grow within the context of a supportive group. By fostering mutual understanding and collaboration, group therapy can address a range of psychological concerns effectively, often complementing or surpassing the...
460
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
3
Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
3
Behavior Therapy
735
Behavior therapy incorporates diverse techniques rooted in classical conditioning principles to address maladaptive behaviors and anxiety disorders. These methods aim to reduce avoidance behaviors, foster adaptive coping mechanisms, and alter associations between stimuli and responses, making them effective in a wide range of therapeutic contexts.
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
735


